Lombard Odier Asset Management Europe Ltd Lowers Stake in Corteva, Inc. $CTVA

Lombard Odier Asset Management Europe Ltd lessened its position in Corteva, Inc. (NYSE:CTVA) by 11.9% in the first quarter, HoldingsChannel.com reports. The institutional investor owned 166,048 shares of the company’s stock after selling 22,426 shares during the period. Lombard Odier Asset Management Europe Ltd’s holdings in Corteva were worth $13,900,000 at the end of the most recent quarter.

A number of other hedge funds have also recently bought and sold shares of the company. Vanguard Group Inc. grew its stake in Corteva by 0.4% in the 4th quarter. Vanguard Group Inc. now owns 80,536,951 shares of the company’s stock worth $5,398,392,000 after acquiring an additional 317,538 shares during the period. State Street Corp lifted its stake in shares of Corteva by 3.7% during the 4th quarter. State Street Corp now owns 36,570,876 shares of the company’s stock worth $2,451,346,000 after purchasing an additional 1,290,071 shares during the period. Franklin Resources Inc. lifted its stake in shares of Corteva by 4.3% during the 4th quarter. Franklin Resources Inc. now owns 19,537,500 shares of the company’s stock worth $1,309,599,000 after purchasing an additional 805,873 shares during the period. Harris Associates L P boosted its holdings in shares of Corteva by 168.1% during the fourth quarter. Harris Associates L P now owns 17,026,221 shares of the company’s stock worth $1,141,268,000 after purchasing an additional 10,675,052 shares during the last quarter. Finally, Northern Trust Corp boosted its holdings in shares of Corteva by 5.0% during the fourth quarter. Northern Trust Corp now owns 11,731,834 shares of the company’s stock worth $786,385,000 after purchasing an additional 562,550 shares during the last quarter. Institutional investors and hedge funds own 81.54% of the company’s stock.

Corteva Stock Up 0.3%

NYSE:CTVA opened at $78.98 on Monday. The company has a debt-to-equity ratio of 0.07, a quick ratio of 1.10 and a current ratio of 1.52. The company has a market capitalization of $52.83 billion, a price-to-earnings ratio of 52.31, a price-to-earnings-growth ratio of 2.39 and a beta of 0.57. Corteva, Inc. has a one year low of $60.53 and a one year high of $90.97. The stock has a 50-day simple moving average of $82.15 and a 200 day simple moving average of $79.63.

Corteva (NYSE:CTVA) last announced its quarterly earnings data on Thursday, July 30th. The company reported $2.30 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.24 by $0.06. Corteva had a return on equity of 10.18% and a net margin of 5.66%.The firm had revenue of $6.38 billion for the quarter, compared to analysts’ expectations of $6.60 billion. During the same quarter in the prior year, the firm posted $2.20 earnings per share. Corteva’s revenue for the quarter was down 1.2% compared to the same quarter last year. Corteva has set its FY 2026 guidance at 3.600-3.800 EPS. Sell-side analysts predict that Corteva, Inc. will post 3.75 EPS for the current fiscal year.

Corteva Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 15th. Investors of record on Tuesday, September 1st will be paid a dividend of $0.18 per share. The ex-dividend date is Tuesday, September 1st. This represents a $0.72 annualized dividend and a yield of 0.9%. Corteva’s dividend payout ratio (DPR) is 47.68%.

Trending Headlines about Corteva

Here are the key news stories impacting Corteva this week:

• Positive Sentiment: Corteva reported second-quarter adjusted EPS of $2.30, exceeding the $2.24 analyst consensus and rising from $2.20 a year earlier. Seed pricing, productivity improvements, demand for newer genetics and traits, and growth in Crop Protection products supported margins. Reuters earnings report
• Positive Sentiment: The company raised its fiscal 2026 EPS outlook to $3.60-$3.80, reflecting strong first-half performance, operating improvements and growth platforms. Management also said it remains on track for the planned October 1 Vylor spin-off, a potential catalyst for improved business focus and valuation. Corteva first-half results and outlook
• Positive Sentiment: Analyst commentary remains broadly constructive: Corteva has outperformed the broader market and agriculture-focused ETFs, while brokerages maintain a consensus “Moderate Buy” rating. Momentum-focused analysis also highlights the company’s improving execution and fundamentals. Brokerage consensus rating
• Neutral Sentiment: Despite the earnings beat and higher guidance, one analysis argues that much of Corteva’s improved execution is already reflected in the stock, leaving limited upside unless earnings growth accelerates. Corteva valuation analysis
• Negative Sentiment: Second-quarter revenue was $6.38 billion, below the $6.60 billion consensus and down 1.2% year over year. The sales miss, together with competitive pricing pressure, appears to be the main reason the stock moved lower despite the profit beat and raised outlook. Corteva second-quarter earnings summary

Analyst Ratings Changes

A number of research analysts have recently commented on the stock. Jefferies Financial Group upped their price objective on shares of Corteva from $95.00 to $97.00 in a research note on Thursday, May 7th. Weiss Ratings raised Corteva from a “hold (c)” rating to a “hold (c+)” rating in a research report on Thursday, May 7th. Zacks Research upgraded shares of Corteva from a “hold” rating to a “strong-buy” rating in a research note on Monday, July 13th. Bank of America raised their price target on shares of Corteva from $90.00 to $96.00 and gave the company a “buy” rating in a report on Monday, July 20th. Finally, Morgan Stanley lifted their price target on shares of Corteva from $84.00 to $95.00 and gave the stock an “overweight” rating in a research note on Thursday, May 28th. One research analyst has rated the stock with a Strong Buy rating, thirteen have issued a Buy rating and eight have issued a Hold rating to the company. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $90.19.

About Corteva

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.